These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 9892851)

  • 1. Decrease of the number of opioid receptors and of the responsiveness to morphineduring neuronal differentiation induced by 17beta-estradiol in estrogen receptor-transfected neuroblastoma cells (SK-ER3).
    Maggi R; Ma ZQ; Pimpinelli F; Maggi A; Martini L
    Neuroendocrinology; 1999 Jan; 69(1):54-62. PubMed ID: 9892851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of opioid receptors in rat sensory neurons in culture.
    Chen JJ; Dymshitz J; Vasko MR
    Mol Pharmacol; 1997 Apr; 51(4):666-73. PubMed ID: 9106633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factors activate estrogen receptor to control the growth and differentiation of the human neuroblastoma cell line SK-ER3.
    Ma ZQ; Santagati S; Patrone C; Pollio G; Vegeto E; Maggi A
    Mol Endocrinol; 1994 Jul; 8(7):910-8. PubMed ID: 7984152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SK-ER3 neuroblastoma cells as a model for the study of estrogen influence on neural cells.
    Agrati P; Garnier M; Patrone C; Pollio G; Santagati S; Vegeto E; Maggi A
    Brain Res Bull; 1997; 44(4):519-23. PubMed ID: 9370219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective and interactive down-regulation of mu- and delta-opioid receptors in human neuroblastoma SK-N-SH cells.
    Baumhaker Y; Gafni M; Keren O; Sarne Y
    Mol Pharmacol; 1993 Aug; 44(2):461-7. PubMed ID: 8394999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demonstration of kappa 3-opioid receptors in the SH-SY5Y human neuroblastoma cell line.
    Cheng J; Standifer KM; Tublin PR; Su W; Pasternak GW
    J Neurochem; 1995 Jul; 65(1):170-5. PubMed ID: 7790858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. cAMP accumulation in opioid-sensitive SH-SY5Y neuroblastoma cells is modified by estradiol and progesterone.
    Ratka A; Hochhaus G; Wissler RN; Simpkins JW
    Mol Cell Endocrinol; 1991 Jul; 78(3):155-62. PubMed ID: 1663875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical and pharmacological characterization of mu, delta and kappa 3 opioid receptors expressed in BE(2)-C neuroblastoma cells.
    Standifer KM; Cheng J; Brooks AI; Honrado CP; Su W; Visconti LM; Biedler JL; Pasternak GW
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1246-55. PubMed ID: 7932177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of mu and delta opiate receptors by morphine, selective agonists and antagonists and differentiating agents in SH-SY5Y human neuroblastoma cells.
    Zadina JE; Harrison LM; Ge LJ; Kastin AJ; Chang SL
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1086-96. PubMed ID: 7932156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of chronic morphine exposure on opioid inhibition of adenylyl cyclase in 7315c cell membranes: a useful model for the study of tolerance at mu opioid receptors.
    Puttfarcken PS; Werling LL; Cox BM
    Mol Pharmacol; 1988 May; 33(5):520-7. PubMed ID: 2835651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Internalization and down-regulation of mu opioid receptors by endomorphins and morphine in SH-SY5Y human neuroblastoma cells.
    Horner KA; Zadina JE
    Brain Res; 2004 Dec; 1028(2):121-32. PubMed ID: 15527737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different subtypes of opioid receptors have different affinities for G-proteins.
    Polastron J; Jauzac P
    Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):389-401. PubMed ID: 7920183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen modulation of catecholamine synthesis and monoamine oxidase A activity in the human neuroblastoma cell line SK-ER3.
    Ma ZQ; Bondiolotti GP; Olasmaa M; Violani E; Patrone C; Picotti GB; Maggi A
    J Steroid Biochem Mol Biol; 1993 Dec; 47(1-6):207-11. PubMed ID: 7903862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Properties of delta opioid receptor in neuroblastoma NS20Y: receptor activation and neuroblastoma proliferation.
    Law PY; Bergsbaken C
    J Pharmacol Exp Ther; 1995 Jan; 272(1):322-32. PubMed ID: 7815347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of specific opioid binding sites in neural membranes from the myenteric plexus of porcine small intestine.
    Townsend D; Portoghese PS; Brown DR
    J Pharmacol Exp Ther; 2004 Jan; 308(1):385-93. PubMed ID: 14569065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphine sulfate concomitantly decreases neuronal differentiation and opioid receptor expression in mouse embryonic stem cells.
    Dholakiya SL; Aliberti A; Barile FA
    Toxicol Lett; 2016 Apr; 247():45-55. PubMed ID: 26877219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SK-N-BE: a human neuroblastoma cell line containing two subtypes of delta-opioid receptors.
    Polastron J; Mur M; Mazarguil H; Puget A; Meunier JC; Jauzac P
    J Neurochem; 1994 Mar; 62(3):898-906. PubMed ID: 8113811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a triple opioid system in the human neuroblastoma NMB cell line.
    Baumhaker Y; Ben-Dor T; Bar-Hamburger R; Sarne Y
    Brain Res; 1994 Nov; 665(1):94-100. PubMed ID: 7882024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogenic control of monoamine oxidase A activity in human neuroblastoma cells expressing physiological concentrations of estrogen receptor.
    Ma ZQ; Violani E; Villa F; Picotti GB; Maggi A
    Eur J Pharmacol; 1995 Sep; 284(1-2):171-6. PubMed ID: 8549621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mu and delta opioid receptor desensitization in undifferentiated human neuroblastoma SHSY5Y cells.
    Prather PL; Tsai AW; Law PY
    J Pharmacol Exp Ther; 1994 Jul; 270(1):177-84. PubMed ID: 8035314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.